Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica  by Chan, Kelvin et al.
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Ethnopharmacological  relevance:  Studies  on  traditional  Chinese  medicine  (TCM),  like those  of  other  sys-
tems  of  traditional  medicine  (TM), are  very  variable  in their  quality,  content  and  focus,  resulting  in issues
around  their  acceptability  to  the  global  scientiﬁc  community.  In an  attempt  to address  these  issues,  an
European  Union  funded  FP7  consortium,  composed  of both  Chinese  and  European  scientists  and  named
“Good  practice  in traditional  Chinese  medicine”  (GP-TCM),  has  devised  a series  of  guidelines  and  tech-
nical notes  to facilitate  good  practice  in  collecting,  assessing  and  publishing  TCM literature  as  well  as
highlighting  the scope  of information  that  should  be in  future  publications  on  TMs.  This  paper  sum-
marises  these  guidelines,  together  with  what  has  been  learned  through  GP-TCM  collaborations,  focusing
on some  common  problems  and  proposing  solutions.  The  recommendations  also  provide  a template  for
the evaluation  of other  types  of  traditional  medicine  such  as Ayurveda,  Kampo  and  Unani.
Materials  and methods:  GP-TCM  provided  a  means  by  which  experts  in  different  areas  relating  to  TCM
were  able  to  collaborate  in forming  a literature  review  good  practice  panel  which  operated  through  e-mail
exchanges,  teleconferences  and  focused  discussions  at annual  meetings.  The  panel  involved  coordinators
and  representatives  of  each  GP-TCM  work  package  (WP)  with  the  latter  managing  the testing  and  reﬁning
of  such  guidelines  within  the context  of their  respective  WPs  and  providing  feedback.
Results:  A Good  Practice  Handbook  for  Scientiﬁc  Publications  on  TCM  was  drafted  during  the  three  years
of  the consortium,  showing  the value  of  such  networks.  A “deliverable  – central  questions  –  labour
division”  model  had  been  established  to  guide  the literature  evaluation  studies  of  each  WP.  The  model
investigated  various  scoring  systems  and  their  ability  to provide  consistent  and  reliable  semi-quantitative
assessments  of  the literature,  notably  in  respect  of  the  botanical  ingredients  involved  and  the  scientiﬁc
quality  of  the  work  described.  This resulted  in  the  compilation  of  (i)  a robust  scoring  system  and  (ii) a
set of minimum  standards  for  publishing  in  the  herbal  medicines  ﬁeld,  based  on  an  analysis  of  the  main
blished  TCM  literature.problems  identiﬁed  in pu∗ Corresponding author at: Building 5-Campbelltown, Locked Bag 1797, Penrith, NSW 2751, Australia. Tel.: +61 2 4620 3837; fax: +61 2 4620 3291.
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Conclusion:  Good  quality,  peer-reviewed  literature  is crucial  in  maintaining  the  integrity  and  the  reputa-
tion of  the  herbal  scientiﬁc  community  and  promoting  good  research  in  TCM.  These  guidelines  provide  a
clear  starting  point  for this  important  endeavour.  They  also  provide  a platform  for  adaptation,  as  appro-
priate,  to other  systems  of  traditional  medicine.
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o. General principles
An aim of the European Union (EU) funded consortium network
n “Good practice in traditional Chinese medicine” (GP-TCM) was
o collect accurate and reliable information on all aspects of tra-
itional Chinese medicine (TCM) from the vast number of sources
vailable, including websites, books and academic journals, and col-
ate it in a form suitable for distribution to the scientiﬁc community.
t was soon recognized that this was a complex and daunting task,
iven the great variation in format and quality of TCM information
n both Chinese and English. A Literature Review Good Practice Panel
as therefore set up to develop guidelines on collecting and assess-
ng published information on TCM research. The panel involved
oordinators and representatives from the different work pack-
ges (WPs) that formed the GP-TCM consortium, with each WP
elving into a speciﬁc area of TCM research and development.
he present paper identiﬁes and discusses the major problems
ncountered when reviewing TCM literature, and proposes work-
ble solutions, which are relevant for all types of traditional
edicine.
Common guidelines on an effective methodology for review-
ng and analysing the literature needed to be developed to form a
asis for the assessment of the information. Reliable data consti-
ute the basis for scientiﬁc evidence and evidence-based practice,
ncluding information about the medicinal plants being used such
s plant name, part used, collection data, post harvest processing,  stor-
ge, chemical analysis, criteria for selection, relevance of in vitro and
n vivo assays to traditional use,  as well as the suitability of the meth-
ds used to analyse the resulting data and the robustness of the
onclusions. Processes are also needed to store, retrieve, share and
pdate information. These procedures are fundamental to produc-
ng an accurate and useful information resource that can be used for
epeating experiments and registration of evidence-based herbal
edicines.
The application of functional genomics (a combination of -omics
echnologies and biological function studies) in combination with
ood quality information about the drugs (herbal or non-herbal)
eing tested is thought to be the most interesting and relevant
ay forward in traditional medicines research. This is because
omplex syndrome differentiation patterns are used for diagnosis,
ollowed by treatment with complex drug formulae, a character-
stic of all traditional medical systems and also very relevant to
esearch in other ethnic traditional medicine such as Ayurveda,
ampo and Unani. Linked keywords were emphasised through
iterature searches, and terms such as “omic(s)”, “genomic(s)”, “pro-
eomic(s)”, “metabolomics(s)”, “metabonomic(s)” were combined
ith “functional”; “array”; “high-content”; “information-rich”; “high-
hroughput”; “state-of-the-art TCM research”; “problems”; “potential
olutions”; “good practice(s) and guideline(s)”, as well as “priorities
or the EU and its member states”, and “difﬁcult diseases in the EU”.
hese latter refer to common diseases and top killers in EU member
tates, that are not satisfactorily treated by conventional medicine.
In the course of an initial analysis of a selection of papers on
erbal medicines, the variability of subjective assessments by indi-
idual researchers soon became apparent. Different approaches
nd criteria were used to evaluate the same report, as well as
or judging its relevance to the data collected. Therefore, a means
f assessing and ensuring the consistency of these evaluations© 2012 Elsevier Ireland Ltd. 
became an imperative at the outset. Both overlapping and spe-
ciﬁc approaches were needed to present data in a usable format
to facilitate sharing of resources and to avoid duplication of effort
and costs.
It is an absolute pre-requisite that any research done on the
activity of a traditional medicine needs to be based on a thorough
identiﬁcation and speciﬁcation of the material used, whether of
botanical, animal or mineral origin. Guidance is given here on all
aspects of the proper deﬁnition of botanical materials as an exam-
ple, but equivalent guidelines are by evidence needed for other
ingredients (i.e. animals and minerals), common in Chinese materia
medica (CMM)  and other forms of traditional medicine.
2. Good practice guidelines for reviewing TCM literature
2.1. Interpreting and using Chinese materia medica (CMM)
names
The names of CMM  used in the literature are very variable
owing largely to the lack of a CMM  international name stan-
dard. As a result, the same CMM  can be described using different
names and different combinations of name types e.g. different Latin
scientiﬁc names, Latin pharmaceutical names as used in some phar-
macopoeia, common names in various languages, Chinese names
(using both simpliﬁed and traditional characters), transliterated
names such as pinyin names and their counterparts from Japanese
and other Asian languages. Different terms are also involved in the
description of the medicinal plant parts, their processing, cooking
and extraction methods, the types of preparation which result from
these processes, the composition of Fufang (TCM formulae com-
prising at least two  CMMs)  and the dosage forms of individual TCM
products. The only type of name that is designed to refer unambigu-
ously to a single species is the Latin scientiﬁc botanical name; yet
in the course of reviewing published papers, it was observed that
such names were infrequently used, if at all, causing ambiguity and
uncertainty about the precise plant species involved and hence the
scientiﬁc integrity of the research.
Even when Latin scientiﬁc names were available, problems were
encountered in recognizing some of these names relative to those
provided in ofﬁcial (government-recognised) texts such as the
national Pharmacopoeias for China, Japan and the European Phar-
macopoeia. This is largely due to a gradual mis-application (e.g.
mis-spelling) in TCM texts of some Latin scientiﬁc names over time,
coupled with the fact that many TCM herbs may  be sourced from
more than one species which each sharing the same Chinese, pin
yin or pharmaceutical name. This complexity in CMM  naming plus
the absence of a standardized CMM  naming index has often led to
confusion, not least amongst TCM researchers in the West. Making
sense of this names maze is a difﬁcult and time-consuming task.
To demonstrate the complexity of CMM  names in the literature
and the problems arising in trying to interpret them, a pilot study
was carried out on the synonymies and possible confusions or adul-
terations of 15 popular CMMs  that have high sales in Europe. The
guidelines and scoring systems which have subsequently emerged
Open access under CC BY-NC-ND license.aim to minimise confusion about CMM  names, enhance literature
searching and provide robust scientiﬁc ‘benchmarks’ for evaluating
individual publications. Table 1 provides a preview of the informa-
tion obtained from the pilot study.
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Owing to the challenges shared by many disciplines world-
ide in interpreting medicinal plant names, a project at the
oyal Botanic Gardens Kew, UK, aims to provide a new resource
or bringing clarity to the use and interpretation of medicinal
able 1
 summary of the recommendations relating to CMM  names.a
1. Literature reviewing 
Take care when interpreting CMM names  
i. These recommendations refer to single drug entities
mixtures and formulae is dealt with in section 2.3
Chinese (e.g. ), pin yin (e.g. Mu Dan Pi), E
pharmacopoeia (e.g. Moutan Cortex), unlike Latin
been standardised and their use, spelling and oc
species to which they refer vary from publication 
monographs in the Chinese Pharmacopoeia vary
from one edition to the next. Furthermore a CMM
sourced from a single species, for example the C
Yi’) as described in the 2010 edition of the Chine
legitimately sourced from the flower buds of 3 diff
biondii Pamp., M. denudata  Desr. or M. spren
reasons that pharmacopoeia, pin yin and other ve
potentially misleading and Latin names should ne
names alone.     
ii. In contrast, there are formal and internationally adop
creating Latin scientific names for plant species a
physical plant specimens.  It is these procedures
names scientific and devoid of ambiguity; these p
internationally agreed guidelines laid down in the
Botanical Nomenclature (ICBN), J. McNeill et al. 
It follows, therefore, that if a CMM name in the lite
Latin scientific name (e.g. Cornus officinalis Sie
is unclear which species is being described and 
made. Latin scientific names must never be deriv
these would not comply with the requirements of
2.  Assessing whether CMM source plants have bee
The use of a Latin scientific name does not always i
identification since such names can be misapplied. 
• While a Latin scientific name (e.g. Cornus officinal 
designed to refer unambiguously to an individual
needed to show that the entity described has bee
Essentially, naming and identification are separ
the latter, literature reviewers need to check that
herbarium specimen (i.e. a dried, flattened speci
ideally with key identification char acters such a
such ‘vouchers’ have been botanically identified 
Where CMM publications lack such verified vouc
uncertain and the associated research should be
(see   2.2.1).  acology 140 (2012) 469– 475 471
plant names worldwide (including TCM names); for more infor-
mation see the Medicinal Plant Names Index and Information
Service (MPNI) (http://www.kew.org/science/directory/projects/
MPNI.html).
; the naming of traditional 
.4. CMM names, be they 
nglish (e.g. Moutan) or 
 scientific names, have not 
casionally even the plant 
to publication; even the 
 in their species delimitation 
 is not always traditionally 
MM ‘Magnoliae Flos’ (or ‘Xin 
se Pharmacopoeia can be 
erent Magnolia species: M. 
geri  Pamp. It is for these 
rnacular names are 
ver be derived from CMM 
ted procedures for 
nd cross-referencing them to 
 that make Latin scientific 
rocedures are bound by 
 International Code of  
2006.     
rature is not linked to a  
b. & Zucc.), by definition, it 
assumptions should not be 
ed from CMM names ; 
 good research in CMM.
n correctly identified 
mply correct botanical  
 
is Siebold & Zucc.) is  
 species, validation is 
n correctly identified.  
ate steps. For evidence of 
 a CMM has a voucher 
men of the whole plant, 
s flowers or fruits) and that 
by a qualified botanist.  
hers, species identity is
 treated with caution 
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Table 1 (Continued )
3. For purposes of publishing 
Naming of CMM 
Where verified vouchers of CMM source plants are available (and hence the 
botanical identity is certain) adopt the  minimum names format  below when
describing CMM in publications.  This format provides the minimum information 
needed to determine the species, the plant part and the type of processing that a 
single CMM represents. 
Minimum Names Format
Latin scientific name + author + plant part(s) + (if relevant) processing
   e.g. 
Glycyrrhiza uralensis Fisch., root and rhizome, honeyed 
Alisma oriental e (Sam.) Juz., tuber, salted 
          Cornus officinalis Sieb. & Zucc., fructus        
Note: plant parts and processing can be given in Latin or English
Additional types of name can be added optionally (such as ‘pharmacopoeia’, ‘pinyin’ 
and ‘vernacular’ names) but this does make for long and clumsy names.  e.g. 
Trichosanthes kirilowii Maxim., seed, stir-fried (chao gua lou zi, Trichosanthes
Semen Tostum)  
Use of Latin names 
• When using Latin scientific names always include authors, e.g. Cornus
officinalis Siebold & Zucc.) and state the location of verified voucher
specimens. Do not derive Latin scientific names from CMM names  (see 
point 1 above).
• Check that Latin scientific names are spelt correctly and are ‘validly 
published names’ (i.e. the first time a Latin scientific name is published it
cannot be chosen at random but must comply with the ICBN (see point 1 
above).  To check that Latin scientific names comply with both these 
criteria simply consult the International Plant Names List - IPN I
(http://www.ipni.org).  This is important since many Latin scientific names
appearing in the TCM literature have been inadvertently corrupted (i.e. 
mispelt) over time and once corrupted it is no longer possible to be certain
to which species they refer.  
• Ideally use Latin scientific names that are accepted  names (rather than 
synonyms); online taxonomic sources such as The Plant List (TPL)
(http://www.theplantlist.org/) provide easy access to accepted  names. 
The case for authenticating CMM trade items:
• Where CMM research items lack verified voucher specimens, endeavour to
provide other evidence of drug authenticity using morphological, chemical, 
DNA or other tests as described in authoritative publications, notably
pharmacopoeia, identification monographs and peer-reviewed papers. Such
tests take time and resources, however, and their species-level accuracy
presents a considerable technical challenge compared to the examination of
verified herbarium vouchers where key identification characters are usually
 more accessible and definitive.  
a This table describes botanical naming systems however CMM are also derived from animal parts and minerals. The same limitations and principles for nomenclature are
also  relevant for these CMM.
K. Chan et al. / Journal of Ethnopharm
Table 2
Key issues and difﬁculties identiﬁed during literature review.
• The grading system depends on the objective of the literature review
•  Any grading system is rather subjective and the grading score achieved will
depend on the criteria used to judge it. It is assumed that published papers
in  good (reputable) journals meet minimum standards of quality through
the  peer-reviewing process; however different journal foci and standards
may  result in inconsistency.
•  Even in high impact journals, there is no guarantee that important aspects
such as herbal quality documentation is not overlooked; this is especially
true for many clinical papers in which CMM  source materials may  be
poorly understood.
• Focusing on high technology approaches in the herbal research area, as is
normal for pharmaceutical research, should not be done to the exclusion
of  lower technology ones, since this may  inadvertently overlook equally
signiﬁcant scientiﬁc ﬁndings.
•  The Cochrane group has developed an extensive set of guidelines for
clinical reviews. Such a strict process does not include “not-so-good”
studies. In a TCM reviewing process, however, researchers may need to
include such papers to identify current problems and areas worthy of
improvement and future development. Grading is then essential to
properly classify the reliability of information.
•  Papers which are deemed poor by accepted criteria should be excluded
from consideration when evaluating evidence, as they will lead to
unreliable conclusions; these should be clearly stated, i.e. “xxxx studies
have also been considered but are not reviewed here because of xxx problems”.
• Literature access poses another problem. Few universities outside, or even
inside, China have full access to the Chinese databases and the vast TCM
literature, ranging from classical books to papers published in different
languages and via different media.
• Obtaining accurate and reliable translation of Chinese literature remains a
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hgreat challenge; this is especially true when interpreting specialist TCM
terminology covering herbal reporting, diagnosis and treatment.
.2. Scoring systems for literature
A scoring system to evaluate the quality of papers is essential
n any extensive review of the literature to ensure consistency
nd transparency of the judgments made. Such scoring systems
an be used to calculate the proportions of papers that meet dif-
erent stringency of quality controls, either at laboratory level,
t research documentation level or at journal editorial level. Low
cores require careful interpretation. They can, but do not necessar-
ly, indicate poor research quality; they can also simply indicate lack
f rigor in reporting experiments as they were published according
o very different types of standards. A low score does not mean the
nformation is wrong, but that its reliability can be questioned in
ome way. Such papers should not be dismissed as (i) some are
ikely to contain useful information; and (ii) for many herbs, only
ery few high quality papers have been published. Although each
iterature research project probably needs its own  system to assess
ts retrieval quality, a common scoring system on reporting the
uality of the herbal identity has been developed using the crite-
ia for good description as explained above. Experience and lessons
rom pilot reviews by all participants pointed to some key issues
nd difﬁculties, which are highlighted in Table 2.
.2.1. A proposed scoring system for herbal quality
A scoring system should be fast, manageable and reasonably
traightforward to enable consensus between users to be achieved.
he scoring system proposed (as shown in Table 3) is based on the
oncept of “essential information”, i.e. information that allows the
eader to unambiguously reproduce the described research, start-
ng from procurement and treatment of herbs under investigation,
 key issue for all herbal research. A three-score system has been
eveloped to assess the following aspects of the herbs or herbal
aterials concerned: (i) identity of plants and plant parts used;
ii) processing procedure; (iii) extraction process. Participants used
his system to assess the quality of retrieved literature on a test
erb, Cornus ofﬁcinalis, and the preliminary ﬁndings of this processacology 140 (2012) 469– 475 473
were reported in a recent meeting of the Consortium for Global-
isation of Chinese Medicine in Shanghai (Sutherland et al., 2011).
Preliminary results showed that information on biological origin
and post-harvest processing in published literature was gener-
ally not reported in satisfactory detail and could be signiﬁcantly
improved by referring to the information detailed in Table 3. The
aim of the full survey when completed will be to provide authors
and editors of journals with the expected quality requirements for
future publications.
2.2.2. A proposed scoring system for selecting a database for
in-silico studies of CMMs
Informatics and computational techniques are more and more
employed for drug development and will most likely con-
tribute in bridging the gulf between the paradigms of TCM
and biomedical science. To this end, (i) a series of databases
are available for CMMs  and TCM botanical information, formu-
lation, usage, phytochemistry and known or potential protein
targets of major phytochemical compounds; and (ii) many soft-
ware are potentially useful (ligand based screening programs,
pharmacophores programs, docking programs, pattern recognition
software, proteomics and/or genomics data visualization tools). The
categorization of such software relevant to CMMs  research, the def-
inition of contents required to create a database for CMMs  in-silico
studies and the scoring for the utility of existing databases have
also been developed within the consortium (Ehrman et al., 2010).
The scoring system underlines the importance of the database con-
tent, of the allowed search versatility and the nature of chemical
structure output.
2.3. Literature retrieval from search engines
2.3.1. Dealing with information sources in English
The consortium proposed to use PUBMED and Google Scholar as
the main literature-retrieving tools, because they are free of charge,
and Scopus and SciFinder for those who  have institutional access.
PUBMED and SciFinder are the most comprehensive databases for
biomedical and chemical literature, respectively. Google Scholar
and Scopus can provide valuable information on the popularity of
any individual papers, listed according to the frequency of cita-
tions, through which comments by peer scientists can be taken as
a reference for analysis.
2.3.2. Dealing with information sources in Chinese
Any comprehensive study of TCM will inevitably require a
search for, and citation of, relevant articles published in Chinese.
Although problematic for most Western scientists to use, several
key Chinese search engines have been identiﬁed and are shown in
Table 4. Evaluating these resources and putting them in context
requires the close collaboration of scientist in both disciplines, and
shows the value of good links between East and West.
2.3.3. Dealing with Chinese-English translation
Accurate translation of information from Chinese into English
is crucial for quality data retrieval, analysis and integration. Pre-
liminary translation of articles of potential interest, prior to more
detailed assessment, can be achieved via the following means:
• Google web Chinese-English translation offers a statistical inter-
pretation based on the Google multilingual databases. This
approach provides an idea of the subject matter contained in
a document but (i) a technically dedicated vocabulary may
be absent from the databases; and (ii) short sentences may
not give enough detail for a statistical interpretation to be
used to make correct vocabulary or subtle grammatical choices,
http://translate.google.com.
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Table 3
Scoring system for documentation of herbal quality.
Botanical Processing Extraction Score
Max. score = 10 Max. score = 5 Max. score = 10 Sufﬁcient information
Botanical origin: a mark from 0 to 10a
Sources of herbs and herbal entities indicated? (speciﬁcation of
location of harvesting or speciﬁcation of a commercial source)
1
Herbs harvested:
Botanical identiﬁcation using Latin scientiﬁc name(s): details on
authenticator and reference number?
2
Herbarium voucher specimens deposited? Voucher number? 3
Herbarium voucher specimen veriﬁed by named botanist 1
DNA bar-coding? 1
Post-harvest treatment speciﬁed? 1
Perceived quality and reproducibility of treatment? 1
Herbs bought from commercial suppliers:
Shop or company name and location? 2
•  Voucher specimens (e.g. dried plant part, extract) deposited?
Voucher number?
or
2
or
•  Quality control according to pharmacopoeial monograph?
or
3
or
• Targeted or non-targeted metabolite analysis 3
DNA bar-coding? 2
Post-harvest treatment (drying, washing, etc.)? 1
Perceived quality and reproducibility of treatment? 1
Herbal processing: a mark from 0 to 5a referring to processing procedures in preparing the CMM  decoction pieces (i.e. washing, drying, slicing, boiling, steaming, etc.)
Absence of processing clearly indicated or deduced? 5
Perceived quality and reproducibility of process? 1 to 5
Extraction: a mark from 0 to 10a
Detailed extraction procedure? 1
Yield? 2
Perceived quality and reproducibility of process? 2
Are  the extracts characterised?
Chromatographic proﬁling?
or
2
and/or
Targeted determination of key constituent(s)? 3
•
•
c
t
i
T
Kor
Non-targeted metabolomics
a The total score is obtained by summation of scores attributed to each item.
The Systran web Chinese-English translation offers a hybrid
approach by mixing linguistic and statistical techniques, incorpo-
rating a classical lexical dictionary with a choice of terminology.
The lack of a globally recognised TCM dictionary for speciﬁc
terminology in English language still limits the accuracy of trans-
lated text.
http://www.systranet.com/, http://www.systran.co.uk/
translation-products/desktop/systran-premium-translator.Translational tools are still crude and do not allow for an appre-
iation of the intricacies of scientiﬁc papers, and especially given
he complexity of TCM vocabulary. In response to this unmet need
n the TCM scientiﬁc community, Beijing East Linden Co. Ltd.,
able 4
ey search engines for information published in Chinese.
Eastlinden information on TCM patents:
http://www.eastlinden.net/NewsShow.aspx?news id=20081127102018850246
TCMonline and SinoMed developed and managed by the China Academy of
Chinese Medical Sciences and some English online platforms on
Traditional Chinese Medical Literature Analysis & Retrieval System and
Traditional Chinese Drug Database:
http://www.cintcm.ac.cn
http://sinomed.imicams.ac.cn
http://www.cintcm.comhttp://cowork.cintcm.com/engine/windex1.jsp
Tsinghua Tongfang Knowledge Network Technology Ltd. provides access to
original Chinese publications including degree thesis:
http://www.cnki.net
Wanfang Data Ltd. provides access to original Chinese publications:
http://www.wanfangdata.com.cn/and/or
3
member of the GP-TCM consortium, has been working on an
enriched TCM vocabulary in multiple languages and a comput-
erised translational system dedicated to TCM literature. However,
this system is still not ready for a full-scale trial. Electronic transla-
tion tools are unlikely to interpret all the subtleties of the paper so
collaboration with scholars from China and those who understand
both Chinese and English, as well as possessing TCM knowledge,
remains essential for ensuring the accuracy of translation.
2.3.4. Dealing with TCM formulae and products with multiple
names and languages
An exhaustive literature search needs to consider the many syn-
onyms used by various authors to identify the botanical material
they investigated, which can be a weary task. The difﬁculty is even
more extensive for Chinese herbs/herbal formulae that are very
often quite differently worded. These formulae, which may  be avail-
able as proprietary medicines as well as crude herbal mixtures, may
also differ in composition depending on country of origin, man-
ufacturer and even individual practitioner. The following search
strategy has been found helpful:
• For typical TCM formulae, such as Liuwei Dihuang Wan, try all the
different partitions of the pinyin name, e.g. Liuweidihuang (12 hits
in Pubmed, March 2011) vs. Liuwei Dihuang (73 hits)• For formulae that are also commonly used in Japanese Kampo
such as Guifu Dihuang Wan  = Hachimijiogan,  include Kampo
names; for example, 4 hits for Guifu Dihuang vs. 63 for Hachimi-
jiogan.
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and extraction information contained in papers on Cornus Ofﬁcinalis in theK. Chan et al. / Journal of Ethno
For certain formulae such as “Xiao Yao San” (translated to “Free
and Easy Wanderer powders”), an English transliteration of the for-
mula name produced more relevant search results. For example,
“Xiao Yao San + depression”  produced 7 hits, and “Free and Easy
Wanderer + depression”  3 hits. These last 3 papers are most rel-
evant randomized clinical trials that were missed by the ﬁrst
search.
All these search strategies should deﬁnitely be attempted before
eclaring to have conducted a “comprehensive search” for a “sys-
ematic review”.
.4. Some useful software for handling retrieved data
The consortium recommends the use of easily available, open-
ccess and widely used software as a prerequisite to the collection
nd storage of retrieved information.
Bibliography searching and reference managing can be
handled using EndNote (www.niles.com) and Refworks
(www.refworks.com), which allow easy access to PubMed
and other online sources and have the ability to store references.
Both can insert and format citations in Word documents, while
Refworks allows a language environment interface in different
languages, including Chinese and English.
The Handbook also provides guidelines for creating sim-
ple databases using software such as Microsoft Access
and Filemaker: http://ofﬁce.microsoft.com/en-us/products/
FX101635841033.aspx,  http://www.ﬁlemaker.com/products/
fmp/tech specs.html.
.5. Types of metadata to collect and report in studies of herbal
edicines
Good practice guidelines for reviewing of publications are given
bove, and obviously these same guidelines should also be fol-
owed when designing and reporting studies of TCM and other
erbal medicines. It is particularly important to include the follow-
ng types of metadata for collected materials: habitat, GPS position
f collection, date and time of collection, season, dry or wet  condi-
ions, sun/shade, morphological and physiological parameters (e.g.
owering, fruiting, young or old leaves), relevant health parame-
ers (e.g. herbivore damage, infections), voucher specimen number
nd method of processing to produce the herbal drug. Preferably,
aterial should be characterized by targeted and/or non-targeted
nalysis of the metabolites, and, if available, according to ofﬁcial
onographs. Voucher specimens need to be stored for future ref-
rence (botanicaI, molecular, chemical). In the case of commercial
reparations, chemical proﬁling and/or pharmacopoeial assays are
ssential as no voucher specimens are available for later veriﬁca-
ion of the botanical identity and chemistry of the studied material.
or industrial products, production batch numbers should also be
tated.
.6. The relationship between literature retrieval and TCM or
erbal medicine scientiﬁc community
Over the course of setting up the Good Practice Handbook for Sci-
ntiﬁc TCM Publications, the Panel has recognised that it is essential
o develop close collaborations with participants in the different
isciplines covered by the GP-TCM WPs, as well as the broader TCM
cientiﬁc and medical professional communities. This will ensure
hat ﬁndings can be viewed in a clinical, cultural and scientiﬁc
ontext and avoid ambiguity when discussing TCM practices and
MMs.  With contributions from different WPs  and senior experts
rom the clinical, scientiﬁc and regulatory sectors in the EU, Chinaacology 140 (2012) 469– 475 475
and worldwide, the Handbook has taken shape as summarised in
Tables 1–4.
Practical metadata on herbal drugs collection and preparation
such as described in Section 2.5 can more or less easily be recorded.
However, it is much more difﬁcult to “measure” traditional knowl-
edge of disease diagnosis and herbal treatment. The number of
times a plant is mentioned for a certain application will give an
indication of its importance, but it remains a signiﬁcant challenge
to qualify and quantify traditional knowledge. This illustrates the
need for including qualiﬁed clinical practitioners in the researches
and further exploring the ﬁeld of ethnopharmacology, even for the
abundantly documented TCMs.
3. Concluding remarks
The importance of considering primary data from published
experimental results, rather than comments and opinions from the
discussions and conclusions of papers, cannot be over-emphasized.
When data are available publicly, anyone may  devise a method for
extracting further information from these data. Moreover, when
the data are recorded in a proper and reproducible way, datasets
from different experiments may  even be integrated and compared
using various data analysis methods (Verpoorte, 2012).
Over the past three years, the Literature Review Good Practice
Panel has coordinated the efforts of the GP-TCM consortium to
develop a Good Practice Handbook for Scientiﬁc TCM Publications,
to be built upon as new science and technologies emerge.
The focus of this paper is on the identiﬁcation of CMM  to ensure
scientiﬁc accuracy in publications and their safe use in practice.
However, the principles expounded here are equally applicable to
the identiﬁcation of the materia medica of other forms of traditional
medicine such as Kampo, Ayurveda and Unani, where the use of
speciﬁc unique terminologies and historical methods of processing
may  also introduce ambiguity. Other modalities of TCM, including
acupuncture and the unique diagnostic approaches of TCM, would
also beneﬁt from the establishment of similar guidelines produced
in a coordinated manner, and these can be adapted to modalities
in other TM systems in due course.
The main ﬁndings and recommendations of this exercise are
that the development, dissemination, implementation and reﬁning
of good practice guidelines in reviewing and publishing research
ﬁndings on traditional medicine are matters of vital importance.
The scientiﬁc community must work together with clinicians and
regulators to further increase the quality and integrity of such
research, as exempliﬁed by this review of issues surrounding
CMMs.  The provision of such high-quality information will support
the modernisation and further development of herbal research, in
order that more patients can beneﬁt from a more widely avail-
able, safer and more evidenced-based practice of TCM in the
future.
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